Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 64

    1.

    Clinical studies with oral lipid based formulations of poorly soluble compounds.

    Fatouros DG, Karpf DM, Nielsen FS, Mullertz A.

    Ther Clin Risk Manag. 2007 Aug;3(4):591-604.PMID: 18472981 [PubMed - in process]Related articlesFree article

    2.

    In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks.

    Fatouros DG, Nielsen FS, Douroumis D, Hadjileontiadis LJ, Mullertz A.

    Eur J Pharm Biopharm. 2008 Aug;69(3):887-98. Epub 2008 Feb 1.PMID: 18367386 [PubMed - indexed for MEDLINE]Related articles

    3.

    Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state.

    Nielsen FS, Petersen KB, Müllertz A.

    Eur J Pharm Biopharm. 2008 Jun;69(2):553-62. Epub 2008 Jan 3.PMID: 18294829 [PubMed - indexed for MEDLINE]Related articles

    4.

    Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound.

    Lue BM, Nielsen FS, Magnussen T, Schou HM, Kristensen K, Jacobsen LO, Müllertz A.

    Eur J Pharm Biopharm. 2008 Jun;69(2):648-57. Epub 2007 Dec 25.PMID: 18280122 [PubMed - indexed for MEDLINE]Related articles

    5.

    Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.

    Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH.

    J Hypertens. 2007 Dec;25(12):2479-85.PMID: 17984670 [PubMed - indexed for MEDLINE]Related articles

    6.

    Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.

    Fatouros DG, Deen GR, Arleth L, Bergenstahl B, Nielsen FS, Pedersen JS, Mullertz A.

    Pharm Res. 2007 Oct;24(10):1844-53. Epub 2007 Apr 26.PMID: 17458683 [PubMed - indexed for MEDLINE]Related articles

    7.

    Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds.

    Nielsen FS, Gibault E, Ljusberg-Wahren H, Arleth L, Pedersen JS, Müllertz A.

    J Pharm Sci. 2007 Apr;96(4):876-92.PMID: 17279513 [PubMed - indexed for MEDLINE]Related articles

    8.

    Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment.

    Sato A, Tarnow L, Nielsen FS, Knudsen E, Parving HH.

    QJM. 2005 Dec;98(12):879-84. Epub 2005 Nov 4.PMID: 16272208 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Insertion of foreign T cell epitopes in human tumor necrosis factor alpha with minimal effect on protein structure and biological activity.

    Nielsen FS, Sauer J, Bäcklund J, Voldborg B, Gregorius K, Mouritsen S, Bratt T.

    J Biol Chem. 2004 Aug 6;279(32):33593-600. Epub 2004 Jun 1.PMID: 15173183 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition.

    Hesse B, Meyer C, Nielsen FS, Sato A, Hove JD, Holm S, Bang LE, Kofoed KF, Svendsen TL, Parving HH, Opie LH.

    Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):362-8. Epub 2003 Dec 5.PMID: 14658015 [PubMed - indexed for MEDLINE]Related articles

    12.

    Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes.

    Kjaer A, Meyer C, Nielsen FS, Parving HH, Hesse B.

    J Nucl Med. 2003 Jan;44(1):19-23.PMID: 12515871 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Preventing diabetic nephropathy: an audit.

    Hansen HP, Lund SS, Rossing P, Tarnow L, Nielsen FS, Jensen T, Parving HH.

    Scand J Clin Lab Invest. 2001;61(6):471-7.PMID: 11681537 [PubMed - indexed for MEDLINE]Related articles

    14.

    Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.

    Nielsen FS.

    Dan Med Bull. 2000 Sep;47(4):249-70. Review. No abstract available. PMID: 11064829 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.

    Tarnow L, Rossing P, Nielsen FS, Fagerudd JA, Poirier O, Parving HH.

    Diabetes Care. 2000 Jan;23(1):30-3.PMID: 10857964 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Biochemical characterization of the heteromeric Bacillus subtilis dihydroorotate dehydrogenase and its isolated subunits.

    Kahler AE, Nielsen FS, Switzer RL.

    Arch Biochem Biophys. 1999 Nov 15;371(2):191-201.PMID: 10545205 [PubMed - indexed for MEDLINE]Related articles

    17.

    Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy.

    Nielsen FS, Hansen HP, Jacobsen P, Rossing P, Smidt UM, Christensen NJ, Pevet P, Vivien-Roels B, Parving HH.

    Diabet Med. 1999 Jul;16(7):555-62.PMID: 10445830 [PubMed - indexed for MEDLINE]Related articles

    18.

    Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy.

    Christensen PK, Rossing P, Nielsen FS, Parving HH.

    Diabet Med. 1999 May;16(5):388-94.PMID: 10342338 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.

    Tarnow L, Sato A, Ali S, Rossing P, Nielsen FS, Parving HH.

    Diabetes Care. 1999 Mar;22(3):491-4.PMID: 10097934 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.

    Parving HH, Tarnow L, Nielsen FS, Rossing P, Mandrup-Poulsen T, Osterby R, Nerup J.

    Diabetes Care. 1999 Mar;22(3):478-83.PMID: 10097932 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    The crystal structure of Lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function.

    Rowland P, Björnberg O, Nielsen FS, Jensen KF, Larsen S.

    Protein Sci. 1998 Jun;7(6):1269-79.PMID: 9655329 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.

    Nielsen FS, Sato A, Ali S, Tarnow L, Smidt UM, Kastrup J, Parving HH.

    Diabetes Care. 1998 May;21(5):804-9.PMID: 9589245 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.

    Fagerudd JA, Tarnow L, Jacobsen P, Stenman S, Nielsen FS, Pettersson-Fernholm KJ, Grönhagen-Riska C, Parving HH, Groop PH.

    Diabetes. 1998 Mar;47(3):439-44.PMID: 9519751 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.

    Hansen HP, Nielsen FS, Rossing P, Jacobsen P, Jensen BR, Parving HH.

    Kidney Int Suppl. 1997 Dec;63:S49-53.PMID: 9407421 [PubMed - indexed for MEDLINE]Related articles

    25.

    Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.

    Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, Parving HH.

    Scand J Clin Lab Invest. 1997 Aug;57(5):427-34.PMID: 9279969 [PubMed - indexed for MEDLINE]Related articles

    26.

    Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathy.

    Nielsen FS, Ali S, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, Kastrup J, Parving HH.

    Diabet Med. 1997 Jul;14(7):538-46.PMID: 9223391 [PubMed - indexed for MEDLINE]Related articles

    27.

    Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.

    Diabetes. 1997 Jul;46(7):1182-8.PMID: 9200654 [PubMed - indexed for MEDLINE]Related articles

    28.

    Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM.

    Tarnow L, Pociot F, Hansen PM, Rossing P, Nielsen FS, Hansen BV, Parving HH.

    Diabetes. 1997 Jun;46(6):1075-6. No abstract available. PMID: 9166682 [PubMed - indexed for MEDLINE]Related articles

    29.

    White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy.

    Nielsen FS, Gaede P, Vedel P, Pedersen O, Parving HH.

    Diabetes Care. 1997 May;20(5):859-63.PMID: 9135956 [PubMed - indexed for MEDLINE]Related articles

    30.

    Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.

    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.

    Diabetes. 1997 Mar;46(3):481-7.PMID: 9032106 [PubMed - indexed for MEDLINE]Related articles

    31.

    The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase A from Lactococcus lactis.

    Rowland P, Nielsen FS, Jensen KF, Larsen S.

    Structure. 1997 Feb 15;5(2):239-52.PMID: 9032071 [PubMed - indexed for MEDLINE]Related articles

    32.

    [Low birth weight--increased risk of diabetic nephropathies?]

    Rossing P, Tarnow L, Nielsen FS, Hansen BV, Brenner BM, Parving HH.

    Ugeskr Laeger. 1996 Dec 30;159(1):41-4. Danish. PMID: 9012073 [PubMed - indexed for MEDLINE]Related articles

    33.

    Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.

    Parving HH, Nielsen FS, Bang LE, Smidt UM, Svendsen TL, Chen JW, Gall MA, Rossing P.

    Diabetologia. 1996 Dec;39(12):1590-7.PMID: 8960847 [PubMed - indexed for MEDLINE]Related articles

    34.

    Glomerular hyperfiltration in microalbuminuric NIDDM patients.

    Vedel P, Obel J, Nielsen FS, Bang LE, Svendsen TL, Pedersen OB, Parving HH.

    Diabetologia. 1996 Dec;39(12):1584-9.PMID: 8960846 [PubMed - indexed for MEDLINE]Related articles

    35.

    Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.

    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.

    Diabetes Care. 1996 Dec;19(12):1382-7.PMID: 8941468 [PubMed - indexed for MEDLINE]Related articles

    36.

    [Albuminuria and glycemic control. The significance for mortality in non-insulin-dependent diabetes mellitus]

    Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH.

    Ugeskr Laeger. 1996 Nov 25;158(48):6907-11. Danish. PMID: 8984753 [PubMed - indexed for MEDLINE]Related articles

    38.

    Fish oil in diabetic nephropathy.

    Rossing P, Hansen BV, Nielsen FS, Myrup B, Hølmer G, Parving HH.

    Diabetes Care. 1996 Nov;19(11):1214-9.PMID: 8908382 [PubMed - indexed for MEDLINE]Related articles

    39.

    Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy.

    Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH.

    Kidney Int. 1996 Aug;50(2):579-85.PMID: 8840289 [PubMed - indexed for MEDLINE]Related articles

    40.

    Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy.

    Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirer O, Parving HH.

    Nephrol Dial Transplant. 1996 Jun;11(6):1019-23.PMID: 8671962 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy.

    Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirier O, Parving HH.

    Diabetes. 1996 Mar;45(3):367-369.PMID: 8593944 [PubMed - indexed for MEDLINE]Related articles

    43.

    Low birth weight. A risk factor for development of diabetic nephropathy?

    Rossing P, Tarnow L, Nielsen FS, Hansen BV, Brenner BM, Parving HH.

    Diabetes. 1995 Dec;44(12):1405-7.PMID: 7589846 [PubMed - indexed for MEDLINE]Related articles

    44.

    Acquired oligonephropathy and diabetic nephropathy.

    Nielsen FS, Gall MA, Parving HH.

    Am J Kidney Dis. 1995 Dec;26(6):898-903.PMID: 7503063 [PubMed - indexed for MEDLINE]Related articles

    45.

    Albuminuria and poor glycemic control predict mortality in NIDDM.

    Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH.

    Diabetes. 1995 Nov;44(11):1303-9.PMID: 7589828 [PubMed - indexed for MEDLINE]Related articles

    46.

    On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy.

    Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, Parving HH.

    Diabetes. 1995 Jul;44(7):783-9.PMID: 7789646 [PubMed - indexed for MEDLINE]Related articles

    47.

    Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy.

    Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borch-Johnsen K.

    Diabetologia. 1995 Jul;38(7):798-803.PMID: 7556981 [PubMed - indexed for MEDLINE]Related articles

    48.

    Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.

    Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH.

    Kidney Int. 1995 Jun;47(6):1726-31.PMID: 7643542 [PubMed - indexed for MEDLINE]Related articles

    49.

    Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients.

    Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH.

    Diabetes. 1995 May;44(5):489-94.PMID: 7729604 [PubMed - indexed for MEDLINE]Related articles

    50.

    Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.

    Nielsen FS, Jørgensen LN, Ipsen M, Voldsgaard AI, Parving HH.

    Diabetologia. 1995 May;38(5):592-8.PMID: 7489843 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...